Evidence map›Paper›PMID 31741768›Full record

ArticleOncoimmunology

Systems analysis of barrier molecule and ARNT-related gene expression regulation in melanoma.

Katie M Leick, Joseph M Obeid, Stefan Bekiranov, Craig L Slingluff

Open access · goldAbstract read
In one paragraph

Article in Oncoimmunology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. NOncogene · 2022
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Katie M LeickDivision of Surgical Oncology, Department of Surgery, University of Virginia, Charlottesville, VA, USA.
Joseph M ObeidDivision of Surgical Oncology, Department of Surgery, University of Virginia, Charlottesville, VA, USA.ORCID 0000-0002-6111-9289
Stefan BekiranovDepartment of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA.ORCID 0000-0002-3177-4346
Craig L SlingluffDivision of Surgical Oncology, Department of Surgery, University of Virginia, Charlottesville, VA, USA.ORCID 0000-0002-6664-4373
Carter Center · USUniversity of Iowa · USUniversity of Virginia · US

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Jay William FOX · 1987 to 2026
$72.1M
Postdoctoral Training Grant for MDs in Surgical Oncology ResearchT32CA163177 · NCI · UNIVERSITY OF VIRGINIA · PI Craig Lee Slingluff, Allan Tsung · 2011 to 2026
$4.6M
MELANOMA VACCINES USING MHC-ASSOCIATED PEPTIDESR01CA057653 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI SLINGLUFF, CRAIG LEE · 1997 to 2012
$3.4M
NCI NIH HHS P30 CA044579NCI NIH HHS R01 CA057653NCI NIH HHS T32 CA163177
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

aryl hydrocarbon receptoraryl hydrocarbon receptor nuclear translocatorBarrier molecule geneschromosome 1q21.3 copy number gainepidermal differentiation complexmelanoma

Identifiers

PMID31741768
PMCPMC6844300
OpenAlexW2977148015

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.